Care to Collaborate: Cydar Medical announces partnership with Medtronic

pharmafile | April 20, 2022 | News story | Research and Development  

Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps software will be introduced to up to 40 new global sites, combining Cydar’s augmented intelligence technology with Medtronic’s services and case support.

The Cydar EV Maps software uses the latest in cloud GPU computing, computer vision and machine learning technology to advance surgical visualisation and decision making across the care pathway. This enables clinicians to create detailed patient-specific 3D maps for procedure planning, image-guided navigation, and post-operative review, resulting in less radiation exposure to the patient and the clinical team, reduced procedure time, and increased delivery confidence.

Medtronic is the first medical technology company to enter a public strategic collaboration in digital endovascular technology to advance aortic patient treatment decisions.

“Medtronic aims to revolutionise endovascular aortic treatment with digital solutions with this phased approach. By collecting data across the patient journey—before, during and after procedure—our goal is to provide analytic support to make our endovascular stent grafts ‘smart’.” said Carolyn Sleeth, VP, General Manager, Aortic.

“By collaborating with Medtronic to bring our Cydar EV Maps solution to up to 40 new hospital sites, we are a step closer to achieving our mission to ensure every image-guided endovascular procedure goes exactly as planned,” added Paul Mussenden, CEO of Cydar.

Lina Adams

Related Content

No items found

Latest content